A new study published in Nature Partner Journals has found that tetrahydrocannabinol (THC) stimulates toxic plaque removal in the brain; toxic plaque in the brain is common in Alzheimer’s disease. The study also found that THC blocks inflammation in the brain, which can damage neurons.
“It is reasonable to conclude that there is a therapeutic potential of cannabinoids for the treatment of Alzheimer’s disease,” says David Schubert, a professor at Salk Institute for Biological Studies who was involved with the study.
“Cannabinoids such as tetrahydrocannabinol stimulate the removal of intraneuronal Aβ, block the inflammatory response, and are protective”, the study states. “Altogether these data show that there is a complex and likely autocatalytic inflammatory response within nerve cells caused by the accumulation of intracellular Aβ, and that this early form of proteotoxicity can be blocked by the activation of cannabinoid receptors.
The full study can be found by clicking here.